TY - JOUR AU - Bennett, J. M. AU - Catovsky, D. AU - Daniel, M. T. AU - Flandrin, G. AU - Galton, D. A. AU - Gralnick, H. R. PY - 1982 DA - 1982// TI - Proposals for the classification of the myelodysplastic syndromes JO - Br J Haematol VL - 51 UR - https://doi.org/10.1111/j.1365-2141.1982.tb08475.x DO - 10.1111/j.1365-2141.1982.tb08475.x ID - Bennett1982 ER - TY - JOUR AU - Harris, N. L. AU - Jaffe, E. S. AU - Diebold, J. AU - Flandrin, G. AU - Muller-Hermelink, H. K. AU - Vardiman, J. PY - 1999 DA - 1999// TI - World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997 JO - J Clin Oncol VL - 17 ID - Harris1999 ER - TY - BOOK AU - Swerdlow, S. H. AU - Campo, E. AU - Harris, N. L. AU - Jaffe, E. S. AU - Pileri, S. A. AU - Stein, H. AU - Vardiman, J. W. PY - 2008 DA - 2008// TI - WHO classification of tumours of haematopoietic and lymphoid tissues PB - WHO Press CY - Geneva, Switzerland ID - Swerdlow2008 ER - TY - JOUR AU - Sanz, G. F. AU - Sanz, M. A. AU - Vallespí, T. AU - Cañizo, M. C. AU - Torrabedella, M. AU - García, S. PY - 1989 DA - 1989// TI - Two regression models and a scoring system for predicting survival and planning treatment in myelodysplastic syndromes: a multivariate analysis of prognostic factors in 370 patients JO - Blood VL - 74 ID - Sanz1989 ER - TY - JOUR AU - Rosa, L. AU - Montuoro, A. AU - Monte, C. PY - 1987 DA - 1987// TI - Myelodysplastic syndromes (MDS) with excess of blasts: identification of subgroups with different prognosis JO - Leuk Res VL - 11 UR - https://doi.org/10.1016/0145-2126(87)90103-2 DO - 10.1016/0145-2126(87)90103-2 ID - Rosa1987 ER - TY - JOUR AU - Estey, E. AU - Plunkett, W. AU - Gandhi, V. AU - Rios, M. B. AU - Kantarjian, H. AU - Keating, M. J. PY - 1993 DA - 1993// TI - Fludarabine and arabinosylcytosine therapy of refractory and relapsed acute myelogenous leukemia JO - Leuk Lymphoma VL - 9 UR - https://doi.org/10.3109/10428199309148532 DO - 10.3109/10428199309148532 ID - Estey1993 ER - TY - JOUR AU - Estey, E. AU - Thall, P. AU - Beran, M. AU - Kantarjian, H. AU - Pierce, S. AU - Keating, M. PY - 1997 DA - 1997// TI - Effect of diagnosis (refractory anemia with excess blasts, refractory anemia with excess blasts in transformation, or acute myeloid leukemia [AML]) on outcome of AML-type chemotherapy JO - Blood VL - 90 ID - Estey1997 ER - TY - JOUR AU - Greenberg, P. AU - Cox, C. AU - LeBeau, M. M. AU - Fenaux, P. AU - Morel, P. AU - Sanz, G. PY - 1997 DA - 1997// TI - International scoring system for evaluating prognosis in myelodysplastic syndromes JO - Blood VL - 89 ID - Greenberg1997 ER - TY - JOUR AU - Guerci, A. P. AU - Feldmann, L. AU - Humbert, J. C. AU - Guerci, O. PY - 1995 DA - 1995// TI - Refractory anemia with excess of blasts: a multivariate analysis of prognostic factors in 91 patients and a simplified scoring system for predicting survival JO - Eur J Haematol VL - 54 UR - https://doi.org/10.1111/j.1600-0609.1995.tb00678.x DO - 10.1111/j.1600-0609.1995.tb00678.x ID - Guerci1995 ER - TY - JOUR AU - Michels, S. D. AU - Saumur, J. AU - Arthur, D. C. AU - Robinson, L. L. AU - Brunning, R. D. PY - 1989 DA - 1989// TI - Refractory anemia with excess of blasts in transformation hematologic and clinical study of 52 patients JO - Cancer VL - 64 UR - https://doi.org/3.0.CO;2-I DO - 3.0.CO;2-I ID - Michels1989 ER - TY - JOUR AU - Morel, P. AU - Hebbar, M. AU - Lai, J. L. AU - Duhamel, A. AU - Preudhomme, C. AU - Wattel, E. PY - 1993 DA - 1993// TI - Cytogenetic analysis has strong independent prognostic value in de novo myelodysplastic syndromes and can be incorporated in a new scoring system: a report on 408 cases JO - Leukemia VL - 7 ID - Morel1993 ER - TY - JOUR AU - Toyama, K. AU - Ohyashiki, K. AU - Yoshidam, Y. AU - Abe, T. AU - Asano, S. AU - Hirai, H. PY - 1993 DA - 1993// TI - Clinical implications of chromosomal abnormalities in 401 patients with myelodysplastic syndromes: a multicentric study in Japan JO - Leukemia VL - 7 ID - Toyama1993 ER - TY - JOUR AU - Cheson, B. D. AU - Greenberg, P. L. AU - Bennett, J. M. AU - Lowenberg, B. AU - Wijermans, P. W. AU - Nimer, S. D. PY - 2006 DA - 2006// TI - Clinical application and proposal for modification of the International Working Group (IWG) response criteria in myelodysplasia JO - Blood VL - 108 UR - https://doi.org/10.1182/blood-2005-10-4149 DO - 10.1182/blood-2005-10-4149 ID - Cheson2006 ER - TY - STD TI - National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: myelodysplastic syndromes guidelines, version 2.2015. 2015. ID - ref14 ER - TY - JOUR AU - Fenaux, P. AU - Mufti, G. J. AU - Hellstrom-Lindberg, E. AU - Santini, V. AU - Finelli, C. AU - Giagounidis, A. PY - 2009 DA - 2009// TI - Efficacy of azacitidine compared with that of conventional care regimens in the treatment of higher-risk myelodysplastic syndromes: a randomised, open-label, phase III study JO - Lancet Oncol VL - 10 UR - https://doi.org/10.1016/S1470-2045(09)70003-8 DO - 10.1016/S1470-2045(09)70003-8 ID - Fenaux2009 ER - TY - JOUR AU - Germing, U. AU - Gattermann, N. AU - Strupp, C. AU - Aivado, M. AU - Aul, C. PY - 2000 DA - 2000// TI - Validation of the WHO proposals for a new classification of primary myelodysplastic syndromes: a retrospective analysis of 1600 patients JO - Leuk Res VL - 24 UR - https://doi.org/10.1016/S0145-2126(00)00088-6 DO - 10.1016/S0145-2126(00)00088-6 ID - Germing2000 ER - TY - JOUR AU - Germing, U. AU - Strupp, C. AU - Kuendgen, A. AU - Aivado, M. AU - Giagounidis, A. AU - Hildebrandt, B. PY - 2006 DA - 2006// TI - Refractory anaemia with excess of blasts (RAEB): analysis of reclassification according to the WHO proposals JO - Br J Haematol VL - 132 UR - https://doi.org/10.1111/j.1365-2141.2005.05853.x DO - 10.1111/j.1365-2141.2005.05853.x ID - Germing2006 ER - TY - JOUR AU - Breccia, M. AU - Latagliata, R. AU - Cannella, L. AU - Carmosino, I. AU - Cuia, R. AU - Frustaci, A. PY - 2009 DA - 2009// TI - Analysis of prognostic factors in patients with refractory anemia with excess of blasts (RAEB) reclassified according to WHO proposal JO - Leuk Res VL - 33 UR - https://doi.org/10.1016/j.leukres.2008.06.033 DO - 10.1016/j.leukres.2008.06.033 ID - Breccia2009 ER - TY - JOUR AU - Greenberg, P. AU - Anderson, J. AU - Witte, T. AU - Estey, E. AU - Fenaux, P. AU - Gupta, P. PY - 2000 DA - 2000// TI - Problematic WHO reclassification of myelodysplastic syndromes. Members of the International MDS Study Group JO - J Clin Oncol VL - 18 ID - Greenberg2000 ER - TY - JOUR AU - Bennett, J. M. PY - 2000 DA - 2000// TI - World Health Organization classification of the acute leukemias and myelodysplastic syndrome JO - Int J Hematol VL - 72 ID - Bennett2000 ER - TY - JOUR AU - Head, D. PY - 2000 DA - 2000// TI - Problematic WHO, reclassification of myelodysplastic syndromes (response 2) JO - J Clin Oncol VL - 18 ID - Head2000 ER - TY - JOUR AU - Breccia, M. AU - Latagliata, R. AU - Carmosino, I. AU - Gentilini, F. AU - D'Elia, G. M. AU - Levi, A. PY - 2007 DA - 2007// TI - Refractory anaemia with excess of blasts in transformation re-evaluated with the WHO criteria: identification of subgroups with different survival JO - Acta Haematol VL - 117 UR - https://doi.org/10.1159/000098957 DO - 10.1159/000098957 ID - Breccia2007 ER - TY - JOUR AU - Silverman, L. R. AU - McKenzie, D. R. AU - Peterson, B. L. AU - Holland, J. F. AU - Backstrom, J. T. AU - Beach, C. L. PY - 2006 DA - 2006// TI - Further analysis of trials with azacitidine in patients with myelodysplastic syndrome: studies 8421, 8921, and 9221 by the Cancer and Leukemia Group B JO - J Clin Oncol VL - 24 UR - https://doi.org/10.1200/JCO.2005.05.4346 DO - 10.1200/JCO.2005.05.4346 ID - Silverman2006 ER - TY - JOUR AU - Dombret, H. AU - Seymour, J. F. AU - Butrym, A. AU - Wierzbowska, A. AU - Selleslag, D. AU - Jang, J. PY - 2015 DA - 2015// TI - International phase 3 study of azacitidine vs conventional care regimens in older patients with newly diagnosed AML with >30% blasts JO - Blood VL - 126 UR - https://doi.org/10.1182/blood-2015-01-621664 DO - 10.1182/blood-2015-01-621664 ID - Dombret2015 ER - TY - JOUR AU - Gavillet, M. AU - Noetzli, J. AU - Blum, S. AU - Duchosal, M. A. AU - Spertini, O. AU - Lambert, J. F. PY - 2012 DA - 2012// TI - Transfusion independence and survival in patients with acute myeloid leukemia treated with 5-azacytidine JO - Haematologica VL - 97 UR - https://doi.org/10.3324/haematol.2012.065151 DO - 10.3324/haematol.2012.065151 ID - Gavillet2012 ER - TY - JOUR AU - Thepot, S. AU - Itzykson, R. AU - Seegers, V. AU - Recher, C. AU - Raffoux, E. AU - Quesnel, B. PY - 2014 DA - 2014// TI - Azacitidine in untreated acute myeloid leukemia: a report on 149 patients JO - Am J Hematol VL - 89 UR - https://doi.org/10.1002/ajh.23654 DO - 10.1002/ajh.23654 ID - Thepot2014 ER - TY - JOUR AU - Cheson, B. D. AU - Bennett, J. M. AU - Kantarjian, H. AU - Pinto, A. AU - Schiffer, C. A. AU - Nimer, S. D. PY - 2000 DA - 2000// TI - Report of an international working group to standardize response criteria for myelodysplastic syndromes JO - Blood VL - 96 ID - Cheson2000 ER - TY - JOUR AU - Cheson, B. D. AU - Bennett, J. M. AU - Kopecky, K. J. AU - Buchner, T. AU - Willman, C. L. AU - Estey, E. H. PY - 2003 DA - 2003// TI - Revised recommendations of the International Working Group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia JO - J Clin Oncol VL - 21 UR - https://doi.org/10.1200/JCO.2003.04.036 DO - 10.1200/JCO.2003.04.036 ID - Cheson2003 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Sill, H. AU - Schlick, K. PY - 2015 DA - 2015// TI - Is it time to redefine response in elderly patients with WHO-acute myeloid leukemia (AML) unfit for intensive chemotherapy? JO - Blood VL - 126 ID - Pleyer2015 ER - TY - JOUR AU - Schuh, A. AU - Dombret, H. AU - Sandhu, I. AU - Seymour, J. F. AU - Stone, R. M. AU - Al-Ali, H. K. AU - Alimena, G. AU - Lewis, I. AU - Sang Kyun, S. AU - Geddes, M. AU - Cilloni, D. AU - Je-Hwan, L. AU - Songer, S. AU - Lucy, L. M. AU - Beach, C. AU - Döhner, H. PY - 2015 DA - 2015// TI - Overall survival (OS) without complete remissions (CR) in older patients with acute myeloid leukemia (AML): azacitidine (AZA) vs conventional care regimens (CCR) in the AZA-AML-001 study JO - Haematologica VL - 100 ID - Schuh2015 ER - TY - JOUR AU - Wattel, E. AU - Botton, S. AU - Luc, L. J. AU - Preudhomme, C. AU - Lepelley, P. AU - Bauters, F. PY - 1997 DA - 1997// TI - Long-term follow-up of de novo myelodysplastic syndromes treated with intensive chemotherapy: incidence of long-term survivors and outcome of partial responders JO - Br J Haematol VL - 98 UR - https://doi.org/10.1046/j.1365-2141.1997.2973114.x DO - 10.1046/j.1365-2141.1997.2973114.x ID - Wattel1997 ER - TY - JOUR AU - Estey, E. AU - Thall, P. AU - Andreeff, M. AU - Beran, M. AU - Kantarjian, H. AU - O'Brien, S. PY - 1994 DA - 1994// TI - Use of granulocyte colony-stimulating factor before, during, and after fludarabine plus cytarabine induction therapy of newly diagnosed acute myelogenous leukemia or myelodysplastic syndromes: comparison with fludarabine plus cytarabine without granulocyte colony-stimulating factor JO - J Clin Oncol VL - 12 ID - Estey1994 ER - TY - JOUR AU - Bernstein, S. H. AU - Brunetto, V. L. AU - Davey, F. R. AU - Wurster-Hill, D. AU - Mayer, R. J. AU - Stone, R. M. PY - 1996 DA - 1996// TI - Acute myeloid leukemia-type chemotherapy for newly diagnosed patients without antecedent cytopenias having myelodysplastic syndrome as defined by French-American-British criteria: a Cancer and Leukemia Group B Study JO - J Clin Oncol VL - 14 ID - Bernstein1996 ER - TY - JOUR AU - Jabbour, E. AU - Kantarjian, H. AU - O'Brien, S. AU - Kadia, T. AU - Malik, A. AU - Welch, M. A. PY - 2013 DA - 2013// TI - Retrospective analysis of prognostic factors associated with response and overall survival by baseline marrow blast percentage in patients with myelodysplastic syndromes treated with decitabine JO - Clin Lymphoma Myeloma Leuk VL - 13 UR - https://doi.org/10.1016/j.clml.2013.05.004 DO - 10.1016/j.clml.2013.05.004 ID - Jabbour2013 ER - TY - JOUR AU - Jabbour, E. AU - Garcia-Manero, G. AU - Ravandi, F. AU - Faderl, S. AU - O'Brien, S. AU - Fullmer, A. PY - 2013 DA - 2013// TI - Prognostic factors associated with disease progression and overall survival in patients with myelodysplastic syndromes treated with decitabine JO - Clin Lymphoma Myeloma Leuk VL - 13 UR - https://doi.org/10.1016/j.clml.2012.11.001 DO - 10.1016/j.clml.2012.11.001 ID - Jabbour2013 ER - TY - JOUR AU - Fenaux, P. AU - Mufti, G. J. AU - Hellstrom-Lindberg, E. AU - Santini, V. AU - Gattermann, N. AU - Germing, U. PY - 2010 DA - 2010// TI - Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.8329 DO - 10.1200/JCO.2009.23.8329 ID - Fenaux2010 ER - TY - JOUR AU - Helm, L. H. AU - Veeger, N. J. AU - Kooy, M. AU - Beeker, A. AU - Weerdt, O. AU - Groot, M. PY - 2013 DA - 2013// TI - Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30 % bone marrow blasts JO - Leuk Res VL - 37 UR - https://doi.org/10.1016/j.leukres.2013.03.022 DO - 10.1016/j.leukres.2013.03.022 ID - Helm2013 ER - TY - JOUR AU - Pollyea, D. A. AU - Zehnder, J. AU - Coutre, S. AU - Gotlib, J. R. AU - Gallegos, L. AU - Abdel-Wahab, O. PY - 2013 DA - 2013// TI - Sequential azacitidine plus lenalidomide combination for elderly patients with untreated acute myeloid leukemia JO - Haematologica VL - 98 UR - https://doi.org/10.3324/haematol.2012.076414 DO - 10.3324/haematol.2012.076414 ID - Pollyea2013 ER - TY - JOUR AU - Oran, B. AU - Weisdorf, D. J. PY - 2012 DA - 2012// TI - Survival for older patients with acute myeloid leukemia: a population-based study JO - Haematologica VL - 97 UR - https://doi.org/10.3324/haematol.2012.066100 DO - 10.3324/haematol.2012.066100 ID - Oran2012 ER - TY - JOUR AU - Kantarjian, H. M. AU - Erba, H. P. AU - Claxton, D. AU - Arellano, M. AU - Lyons, R. M. AU - Kovascovics, T. PY - 2010 DA - 2010// TI - Phase II study of clofarabine monotherapy in previously untreated older adults with acute myeloid leukemia and unfavorable prognostic factors JO - J Clin Oncol VL - 28 UR - https://doi.org/10.1200/JCO.2009.23.3130 DO - 10.1200/JCO.2009.23.3130 ID - Kantarjian2010 ER - TY - JOUR AU - Gardin, C. AU - Turlure, P. AU - Fagot, T. AU - Thomas, X. AU - Terre, C. AU - Contentin, N. PY - 2007 DA - 2007// TI - Postremission treatment of elderly patients with acute myeloid leukemia in first complete remission after intensive induction chemotherapy: results of the multicenter randomized Acute Leukemia French Association (ALFA) 9803 trial JO - Blood VL - 109 UR - https://doi.org/10.1182/blood-2007-02-069666 DO - 10.1182/blood-2007-02-069666 ID - Gardin2007 ER - TY - JOUR AU - Faderl, S. AU - Ravandi, F. AU - Huang, X. AU - Garcia-Manero, G. AU - Ferrajoli, A. AU - Estrov, Z. PY - 2008 DA - 2008// TI - A randomized study of clofarabine versus clofarabine plus low-dose cytarabine as front-line therapy for patients aged 60 years and older with acute myeloid leukemia and high-risk myelodysplastic syndrome JO - Blood VL - 112 UR - https://doi.org/10.1182/blood-2007-11-124602 DO - 10.1182/blood-2007-11-124602 ID - Faderl2008 ER - TY - JOUR AU - Burnett, A. K. AU - Milligan, D. AU - Prentice, A. G. AU - Goldstone, A. H. AU - McMullin, M. F. AU - Hills, R. K. PY - 2007 DA - 2007// TI - A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment JO - Cancer VL - 109 UR - https://doi.org/10.1002/cncr.22496 DO - 10.1002/cncr.22496 ID - Burnett2007 ER - TY - JOUR AU - Faderl, S. AU - Ravandi, F. AU - Huang, X. AU - Wang, X. AU - Jabbour, E. AU - Garcia-Manero, G. PY - 2012 DA - 2012// TI - Clofarabine plus low-dose cytarabine followed by clofarabine plus low-dose cytarabine alternating with decitabine in acute myeloid leukemia frontline therapy for older patients JO - Cancer VL - 118 UR - https://doi.org/10.1002/cncr.27429 DO - 10.1002/cncr.27429 ID - Faderl2012 ER - TY - JOUR AU - Fehniger, T. A. AU - Uy, G. L. AU - Trinkaus, K. AU - Nelson, A. D. AU - Demland, J. AU - Abboud, C. N. PY - 2011 DA - 2011// TI - A phase 2 study of high-dose lenalidomide as initial therapy for older patients with acute myeloid leukemia JO - Blood VL - 117 UR - https://doi.org/10.1182/blood-2010-07-297143 DO - 10.1182/blood-2010-07-297143 ID - Fehniger2011 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Sill, H. AU - Schlick, K. PY - 2015 DA - 2015// TI - Azacitidine in acute myeloid leukemia with >30 % bone marrow blasts and <15 G/L white blood cell count: results from the Austrian Azacitidine Registry of the AGMT study group versus randomized controlled phase III clinical trial data JO - Blood VL - 126 ID - Pleyer2015 ER - TY - JOUR AU - Wang, H. I. AU - Aas, E. AU - Howell, D. AU - Roman, E. AU - Patmore, R. AU - Jack, A. PY - 2014 DA - 2014// TI - Long-term medical costs and life expectancy of acute myeloid leukemia: a probabilistic decision model JO - Value Health VL - 17 UR - https://doi.org/10.1016/j.jval.2013.12.007 DO - 10.1016/j.jval.2013.12.007 ID - Wang2014 ER - TY - JOUR AU - Kantarjian, H. M. AU - Thomas, X. G. AU - Dmoszynska, A. AU - Wierzbowska, A. AU - Mazur, G. AU - Mayer, J. PY - 2012 DA - 2012// TI - Multicenter, randomized, open-label, phase III trial of decitabine versus patient choice, with physician advice, of either supportive care or low-dose cytarabine for the treatment of older patients with newly diagnosed acute myeloid leukemia JO - J Clin Oncol VL - 30 UR - https://doi.org/10.1200/JCO.2011.38.9429 DO - 10.1200/JCO.2011.38.9429 ID - Kantarjian2012 ER - TY - JOUR AU - Miesner, M. AU - Haferlach, C. AU - Bacher, U. AU - Weiss, T. AU - Macijewski, K. AU - Kohlmann, A. PY - 2010 DA - 2010// TI - Multilineage dysplasia (MLD) in acute myeloid leukemia (AML) correlates with MDS-related cytogenetic abnormalities and a prior history of MDS or MDS/MPN but has no independent prognostic relevance: a comparison of 408 cases classified as “AML not otherwise specified” (AML-NOS) or “AML with myelodysplasia-related changes” (AML-MRC) JO - Blood VL - 116 UR - https://doi.org/10.1182/blood-2010-04-279794 DO - 10.1182/blood-2010-04-279794 ID - Miesner2010 ER - TY - JOUR AU - Lindsley, R. C. AU - Mar, B. G. AU - Mazzola, E. AU - Grauman, P. V. AU - Shareef, S. AU - Allen, S. L. PY - 2015 DA - 2015// TI - Acute myeloid leukemia ontogeny is defined by distinct somatic mutations JO - Blood VL - 125 UR - https://doi.org/10.1182/blood-2014-11-610543 DO - 10.1182/blood-2014-11-610543 ID - Lindsley2015 ER - TY - JOUR AU - Gahn, B. AU - Haase, D. AU - Unterhalt, M. AU - Drescher, M. AU - Schoch, C. AU - Fonatsch, C. PY - 1996 DA - 1996// TI - De novo AML with dysplastic hematopoiesis: cytogenetic and prognostic significance JO - Leukemia VL - 10 ID - Gahn1996 ER - TY - JOUR AU - Gajewski, J. L. AU - Ho, W. G. AU - Nimer, S. D. AU - Hirji, K. F. AU - Gekelman, L. AU - Jacobs, A. D. PY - 1989 DA - 1989// TI - Efficacy of intensive chemotherapy for acute myelogenous leukemia associated with a preleukemic syndrome JO - J Clin Oncol VL - 7 ID - Gajewski1989 ER - TY - JOUR AU - Bertoli, S. AU - Bérard, E. AU - Huguet, F. AU - Huynh, A. AU - Tavitian, S. AU - Vergez, F. PY - 2013 DA - 2013// TI - Time from diagnosis to intensive chemotherapy initiation does not adversely impact the outcome of patients with acute myeloid leukemia JO - Blood VL - 121 UR - https://doi.org/10.1182/blood-2012-09-454553 DO - 10.1182/blood-2012-09-454553 ID - Bertoli2013 ER - TY - JOUR AU - Witte, T. AU - Suciu, S. AU - Peetermans, M. AU - Fenaux, P. AU - Strijckmans, P. AU - Hayat, M. PY - 1995 DA - 1995// TI - Intensive chemotherapy for poor prognosis myelodysplasia (MDS) and secondary acute myeloid leukemia (sAML) following MDS of more than 6 months duration. A pilot study by the Leukemia Cooperative Group of the European Organisation for Research and Treatment in Cancer (EORTC-LCG) JO - Leukemia VL - 9 ID - Witte1995 ER - TY - JOUR AU - Montoro, J. AU - Coll, R. AU - Valcarcel, D. AU - Tormo, M. AU - Calbacho, M. AU - Bernal, T. PY - 2014 DA - 2014// TI - IMPACT of therapeutic strategy and time to therapy initiation on clinical evolution in higher-risk myelodysplastic syndromes. A report from Erasme study JO - Blood VL - 124 ID - Montoro2014 ER - TY - JOUR AU - Sekeres, M. A. AU - Elson, P. AU - Kalaycio, M. E. AU - Advani, A. S. AU - Copelan, E. A. AU - Faderl, S. PY - 2009 DA - 2009// TI - Time from diagnosis to treatment initiation predicts survival in younger, but not older, acute myeloid leukemia patients JO - Blood VL - 113 UR - https://doi.org/10.1182/blood-2008-05-157065 DO - 10.1182/blood-2008-05-157065 ID - Sekeres2009 ER - TY - JOUR AU - Ostgard, L. S. AU - Norgaard, J. M. AU - Sengelov, H. AU - Holm, M. S. AU - Jensen, M. K. AU - Kallenbach, M. PY - 2014 DA - 2014// TI - Impact of chemotherapy delay on short- and long-term survival in younger and older AML patients: a Danish population-based cohort study JO - Leukemia VL - 28 UR - https://doi.org/10.1038/leu.2014.157 DO - 10.1038/leu.2014.157 ID - Ostgard2014 ER - TY - JOUR AU - Pelloso, L. AU - Rohr, S. AU - Yamamoto, M. AU - Chauffaille, M. PY - 2013 DA - 2013// TI - Time elapsed from AML diagnosis to induction chemotherapy affects overall survival JO - Journal of Cancer Therapy VL - 4 UR - https://doi.org/10.4236/jct.2013.45108 DO - 10.4236/jct.2013.45108 ID - Pelloso2013 ER - TY - JOUR AU - Wang, J. H. AU - Guo, Q. AU - Ma, Z. X. AU - Ma, Q. L. AU - Yu, M. X. AU - Yin, X. F. PY - 2015 DA - 2015// TI - Impact of chemotherapy delay on overall survival for AML with IDH1/2 mutations: a study in adult Chinese patients JO - PLoS ONE VL - 10 UR - https://doi.org/10.1371/journal.pone.0140622 DO - 10.1371/journal.pone.0140622 ID - Wang2015 ER - TY - JOUR AU - Hasserjian, R. P. AU - Campigotto, F. AU - Klepeis, V. AU - Fu, B. AU - Wang, S. A. AU - Bueso-Ramos, C. PY - 2014 DA - 2014// TI - De novo acute myeloid leukemia with 20–29 % blasts is less aggressive than acute myeloid leukemia with >/=30 % blasts in older adults: a bone marrow pathology group study JO - Am J Hematol VL - 89 UR - https://doi.org/10.1002/ajh.23808 DO - 10.1002/ajh.23808 ID - Hasserjian2014 ER - TY - JOUR AU - Pleyer, L. AU - Stauder, R. AU - Burgstaller, S. AU - Schreder, M. AU - Tinchon, C. AU - Pfeilstocker, M. PY - 2013 DA - 2013// TI - Azacitidine in patients with WHO-defined AML—results of 155 patients from the Austrian Azacitidine Registry of the AGMT-Study Group JO - J Hematol Oncol VL - 6 UR - https://doi.org/10.1186/1756-8722-6-32 DO - 10.1186/1756-8722-6-32 ID - Pleyer2013 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Girschikofsky, M. AU - Linkesch, W. AU - Stauder, R. AU - Pfeilstocker, M. PY - 2014 DA - 2014// TI - Azacitidine in 302 patients with WHO-defined acute myeloid leukemia: results from the Austrian Azacitidine Registry of the AGMT-Study Group JO - Ann Hematol VL - 93 UR - https://doi.org/10.1007/s00277-014-2126-9 DO - 10.1007/s00277-014-2126-9 ID - Pleyer2014 ER - TY - JOUR AU - Quintas-Cardama, A. AU - Ravandi, F. AU - Liu-Dumlao, T. AU - Brandt, M. AU - Faderl, S. AU - Pierce, S. PY - 2012 DA - 2012// TI - Epigenetic therapy is associated with similar survival compared with intensive chemotherapy in older patients with newly diagnosed acute myeloid leukemia JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-06-436055 DO - 10.1182/blood-2012-06-436055 ID - Quintas-Cardama2012 ER - TY - JOUR AU - Ohyashiki, K. AU - Nishimaki, J. AU - Shoji, N. AU - Miyazawa, K. AU - Kimura, Y. AU - Ohyashiki, J. H. PY - 2001 DA - 2001// TI - Re-evaluation of refractory anemia with excess blasts in transformation JO - Leuk Res VL - 25 UR - https://doi.org/10.1016/S0145-2126(01)00054-6 DO - 10.1016/S0145-2126(01)00054-6 ID - Ohyashiki2001 ER - TY - JOUR AU - Arber, D. A. AU - Stein, A. S. AU - Carter, N. H. AU - Ikle, D. AU - Forman, S. J. AU - Slovak, M. L. PY - 2003 DA - 2003// TI - Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival JO - Am J Clin Pathol VL - 119 UR - https://doi.org/10.1309/EM7KCQR4GLMHRCX4 DO - 10.1309/EM7KCQR4GLMHRCX4 ID - Arber2003 ER - TY - JOUR AU - Estey, E. AU - Pierce, S. AU - Kantarjian, H. AU - O'Brien, S. AU - Beran, M. AU - Andreeff, M. PY - 1993 DA - 1993// TI - Treatment of myelodysplastic syndromes with AML-type chemotherapy JO - Leuk Lymphoma VL - 11 UR - https://doi.org/10.3109/10428199309064263 DO - 10.3109/10428199309064263 ID - Estey1993 ER - TY - JOUR AU - Albitar, M. AU - Beran, M. AU - O'Brien, S. AU - Kantarjian, H. AU - Frieriech, E. AU - Keating, M. PY - 2000 DA - 2000// TI - Differences between refractory anemia with excess blasts in transformation and acute myeloid leukemia JO - Blood VL - 96 ID - Albitar2000 ER - TY - JOUR AU - Strupp, C. AU - Gattermann, N. AU - Giagounidis, A. AU - Aul, C. AU - Hildebrandt, B. AU - Haas, R. PY - 2003 DA - 2003// TI - Refractory anemia with excess of blasts in transformation: analysis of reclassification according to the WHO proposals JO - Leuk Res VL - 27 UR - https://doi.org/10.1016/S0145-2126(02)00220-5 DO - 10.1016/S0145-2126(02)00220-5 ID - Strupp2003 ER - TY - JOUR AU - Estey, E. H. AU - Keating, M. J. AU - Dixon, D. O. AU - Trujillo, J. M. AU - McCredie, K. B. AU - Freireich, E. J. PY - 1987 DA - 1987// TI - Karyotype is prognostically more important than the FAB system’s distinction between myelodysplastic syndrome and acute myelogenous leukemia JO - Hematol Pathol VL - 1 ID - Estey1987 ER - TY - JOUR AU - Becker, H. AU - Suciu, S. AU - Ruter, B. H. AU - Platzbecker, U. AU - Giagounidis, A. AU - Selleslag, D. PY - 2015 DA - 2015// TI - Decitabine versus best supportive care in older patients with refractory anemia with excess blasts in transformation (RAEBt)—results of a subgroup analysis of the randomized phase III study 06011 of the EORTC Leukemia Cooperative Group and German MDS Study Group (GMDSSG) JO - Ann Hematol VL - 94 UR - https://doi.org/10.1007/s00277-015-2489-6 DO - 10.1007/s00277-015-2489-6 ID - Becker2015 ER - TY - JOUR AU - Greenberg, P. L. AU - Tuechler, H. AU - Schanz, J. AU - Sanz, G. AU - Garcia-Manero, G. AU - Sole, F. PY - 2012 DA - 2012// TI - Revised international prognostic scoring system for myelodysplastic syndromes JO - Blood VL - 120 UR - https://doi.org/10.1182/blood-2012-03-420489 DO - 10.1182/blood-2012-03-420489 ID - Greenberg2012 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Linkesch, W. AU - Pfeilstöcker, M. PY - 2014 DA - 2014// TI - Azacitidine in patients with acute myeloid leukemia: assessing the potential negative impact of elevated baseline white blood cell count on outcome JO - Blood VL - 124 ID - Pleyer2014 ER - TY - JOUR AU - Pleyer, L. AU - Germing, U. AU - Sperr, W. R. AU - Linkesch, W. AU - Burgstaller, S. AU - Stauder, R. PY - 2014 DA - 2014// TI - Azacitidine in CMML: matched-pair analyses of daily-life patients reveal modest effects on clinical course and survival JO - Leuk Res VL - 38 UR - https://doi.org/10.1016/j.leukres.2014.01.006 DO - 10.1016/j.leukres.2014.01.006 ID - Pleyer2014 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Linkesch, W. AU - Pfeilstöcker, M. AU - Autzinger, E. M. AU - Tinchon, C. AU - Sliwa, T. AU - Lang, A. AU - Sperr, W. R. AU - Geissler, D. AU - Krippl, P. AU - Voskova, D. AU - Rossmann, D. H. AU - Schlick, K. AU - Thaler, J. AU - Halter, B. AU - Machherndl-Spandl, S. AU - Theiler, G. AU - Valent, P. AU - Eckmüllner, O. AU - Greil, R. PY - 2014 DA - 2014// TI - Azacitidine in acute myeloid leukemia: comparison of patients with AML-MRF vs AML-NOS enrolled in the Austrian Azacitidine Registry JO - Blood VL - 124 ID - Pleyer2014 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Linkesch, W. AU - Pfeilstöcker, M. AU - Autzinger, E. M. AU - Tinchon, C. AU - Sliwa, T. AU - Lang, A. AU - Sperr, W. R. AU - Geissler, D. AU - Krippl, P. AU - Voskova, D. AU - Rossmann, D. H. AU - Schlick, K. AU - Thaler, J. AU - Halter, B. AU - Machherndl-Spandl, S. AU - Theiler, G. AU - Valent, P. AU - Eckmüllner, O. AU - Greil, R. PY - 2014 DA - 2014// TI - Azacitidine in patients with acute myeloid leukemia: impact of intermediate-risk vs high-risk cytogenetics on patient outcomes JO - Blood VL - 124 ID - Pleyer2014 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Linkesch, W. AU - Pfeilstöcker, M. AU - Autzinger, E. M. AU - Tinchon, C. AU - Sliwa, T. AU - Lang, A. AU - Sperr, W. R. AU - Geissler, D. AU - Krippl, P. AU - Voskova, D. AU - Rossmann, D. H. AU - Schlick, K. AU - Thaler, J. AU - Halter, B. AU - Machherndl-Spandl, S. AU - Theiler, G. AU - Valent, P. AU - Eckmüllner, O. AU - Greil, R. PY - 2014 DA - 2014// TI - Azacitidine in patients with relapsed/refractory acute myeloid leukemia: retrospective analysis of the Austrian Azacitidine Registry JO - Blood VL - 124 ID - Pleyer2014 ER - TY - JOUR AU - Pleyer, L. AU - Burgstaller, S. AU - Stauder, R. AU - Girschikofsky, M. AU - Linkesch, W. AU - Pfeilstöcker, M. AU - Autzinger, E. M. AU - Tinchon, C. AU - Sliwa, T. AU - Lang, A. AU - Sperr, W. R. AU - Geissler, D. AU - Krippl, P. AU - Voskova, D. AU - Rossmann, D. H. AU - Schlick, K. AU - Thaler, J. AU - Halter, B. AU - Machherndl-Spandl, S. AU - Theiler, G. AU - Valent, P. AU - Eckmüllner, O. AU - Greil, R. PY - 2014 DA - 2014// TI - Azacitidine in patients with treatment-related acute myeloid leukemia: retrospective analysis of the Austrian Azacitidine Registry JO - Blood VL - 124 ID - Pleyer2014 ER - TY - JOUR AU - Almeida, A. AU - Prebet, T. AU - Itzykson, R. PY - 2015 DA - 2015// TI - Clinical outcomes of acute erythroleukemia treated with azacitidine: a retrospective multicenter study JO - Haematalogica VL - 100 ID - Almeida2015 ER - TY - JOUR AU - Pleyer, L. AU - Stauder, R. AU - Thaler, J. AU - Ludwig, H. AU - Pfeilstocker, M. AU - Steinkirchner, S. PY - 2011 DA - 2011// TI - Age- and comorbidity-specific evaluation of azacitidine treatment, response and overall survival in 184 patients in the Austrian Azacitidine Registry JO - Leuk Res VL - 35 ID - Pleyer2011 ER - TY - JOUR AU - Pleyer, L. AU - Stauder, R. AU - Thaler, J. AU - Ludwig, H. AU - Pfeilstöcker, M. AU - Steinkirchner, T. PY - 2011 DA - 2011// TI - Overall survival data of patients with MDS, AML and CMML from the Austrian Azacitidine Registry of 184 consecutive patients JO - Leuk Res VL - 35 ID - Pleyer2011 ER - TY - JOUR AU - Doehner, H. AU - Estey, E. H. AU - Amadori, S. AU - Appelbaum, F. R. AU - Buchner, T. AU - Burnett, A. K. PY - 2010 DA - 2010// TI - Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet JO - Blood VL - 115 UR - https://doi.org/10.1182/blood-2009-07-235358 DO - 10.1182/blood-2009-07-235358 ID - Doehner2010 ER -